Differential Expression of Metallothionein in Gastrointestinal Stromal Tumors and Gastric Carcinomas

Anatomical Record

Volumn 294, Issue 2, 2011, Pages 267-272

  Soo, Eliza Ting Li ^a   NG, Cheng Teng ^a   Yip, George Wai Cheong ^a   Koo, Chuay Yeng ^a   Nga, Min En ^a   Tan, Puay Hoon ^b   Bay, Boon Huat ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Gastric carcinoma; GIST; Immunohistochemistry; Metallothionein; MT 2A

Indexed keywords

MESSENGER RNA; METALLOTHIONEIN II;

ARTICLE; CANCER STAGING; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STOMACH CARCINOMA;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; METALLOTHIONEIN; NEOPLASM STAGING; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78651422456     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21321     Document Type: Article

References (33)

1. Boku N. 2010. Perspectives for personalization in chemotherapy of advanced gastric cancer. Discov Med 9: 84-89.
2. Cajal SR. 1893. Sur les ganglions et plexus nerveux de l'intestin. LR Soc Biol (Paris) 45: 217-223.
3. Cherian MG, Jayasurya A, Bay BH. 2003. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533: 201-209.
4. Coyle P, Philcox JC, Carey LC, Rofe AM. 2002. Metallothionein: the multi-purpose protein. Cell Mol Life Sci 59: 627-647.
5. Dutsch-Wicherek M, Sikora J, Tomaszewska R. 2008. The possible biological role of metallothionein in apoptosis. Front Biosci 13: 4029-4038.
6. Ebert MP, Günther T, Hoffmann J, Yu J, Miehlke S, Schulz HU, Roessner A, Korc M, Malfertheiner P. 2000. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res 60: 1995-2001.
7. Fock KM, Ang TL. 2010. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 25: 479-486.
8. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. 2003. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299: 708-710.
9. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. 1998. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279: 577-580.
10. Janssen AM, van Duijn W, Oostendorp-Van De Ruit MM, Kruidenier L, Bosman CB, Griffioen G, Lamers CB, van Krieken JH, van De Velde CJ, Verspaget HW. 2000. Metallothionein in human gastrointestinal cancer. J Pathol 192: 293-300.
11. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. 1998. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152: 1259-1269.
12. Klaassen CD, Liu J, Choudhuri S. 1999. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39: 267-294.
13. Liegl-Atzwanger B, Fletcher JA, Fletcher CD. 2010. Gastrointestinal stromal tumors. Virchows Arch 456: 111-127.
14. Margoshes M, Vallee B. 1957. A cadmium protein from equine kidney cortex. J Am Chem Soc 79: 4813-4814.
15. Mididoddi S, McGuirt JP, Sens MA, Todd JH, Sens DA. 1996. Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett 85: 17-27.
16. Miettinen M, Lasota J. 2006. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130: 1466-1478.
17. Miettinen M, Makhlouf H, Sobin LH, Lasota J. 2006. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 30: 477-489.
18. Miettinen M, Sarlomo-Rikala M, Kovatich AJ, Lasota J. 1999b. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol 12: 756-762.
19. Miettinen M, Sarlomo-Rikala M, Lasota J. 1998. Gastrointestinal stromal tumours. Ann Chir Gynaecol 87: 278-281.
20. Miettinen M, Sarlomo-Rikala M, Lasota J. 1999a. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 30: 1213-1220.
21. Miettinen M, Sobin LH, Sarlomo-Rikala M. 2000. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 13: 1134-1142.
22. Min KW. 2010. Gastrointestinal stromal tumor: an ultrastructural investigation on regional differences with considerations on their histogenesis. Ultrastruct Pathol 34: 174-188.
23. Panani AD. 2008. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 266: 99-115.
24. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
25. Pedersen M, Larsen A, Stoltenberg M, Penkowa M. 2009. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 44: 29-64.
26. Perez-Gutierrez S, Gonzalez-Campora R, Amerigo-Navarro J, Beato-Moreno A, Sanchez-Leon M, Pareja Megia JM, Virizuela-Echaburu JA, Lopez-Beltran A. 2007. Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications. Pathol Oncol Res 13: 203-208.
27. Ponsaing LG, Kiss K, Hansen MB. 2007. Classification of submucosal tumors in the gastrointestinal tract. World J Gastroenterol 13: 3311-3315.
28. Rossi F, Ehlers I, Agosti V, Socci ND, Viale A, Sommer G, Yozgat Y, Manova K, Antonescu CR, Besmer P. 2006. Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor. Proc Natl Acad Sci USA 103: 12843-12848.
29. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. 1998. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11: 728-734.
30. Thirumoorthy N, Manisenthil Kumar KT, Shyam Sundar A, Panayappan L, Chatterjee M. 2007. Metallothienein: an overview. World J Gastroenterol 13: 993-996.
31. Thuneberg L. 1982. Interstitial cells of Cajal: intestinal pacemaker cells? Adv Anat Embryol Cell Biol 71: 1-130.
32. Torihashi S, Nishi K, Tokutomi Y, Nishi T, Ward S, Sanders KM. 1999. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype. Gastroenterology 117: 140-148.
33. Tuccari G, Giuffre G, Arena F, Barresi G. 2000. Immunohistochemical detection of metallothionein in carcinomatous and normal human gastric mucosa. Histol Histopathol 15: 1035-1041.